OncoQR ML OG - Company Review
OncoQR ML OG - Company ReviewSummary
OncoQR ML OG (OncoQR) is a biotechnology company that offers therapies. The company develops adjustable cancer immunotherapies for the treatment of oncologic diseases. Its TYG100, out licensed to TYG-Oncology, is used for treatment of gastroenterological cancers such as pancreatic, stomach and colon cancers. OncoQR’s other pipeline candidates include OQR 200 for the treatment of breast cancer; OQR 300 and OQR 400 for other cancers. The company’s ACIs are based on the S-TIR technology platform, developed by S-TARget therapeutics GmbH. It uses S-TIR technology platform to generate powerful immune responses against antigens associated with tumors. The company develops therapies for the treatment of pancreatic cancer. OncoQR is headquartered in Vienna, Austria.
This comprehensive company report of OncoQR ML OG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.